Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a primary liver malignancy and accounts for most of the total liver cancer cases. Lack of treatment options and late diagnosis contribute to high mortality rate of HCC. In eukaryotes, translation of messenger RNA (mRNA) to protein is a key process in protein biosynt...
Saved in:
Main Authors: | Felix H. Shek, Sarwat Fatima, Nikki P. Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2012/760928 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
eIF3 engages with 3’-UTR termini of highly translated mRNAs
by: Santi Mestre-Fos, et al.
Published: (2025-01-01) -
Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
by: Zhigang Ren, et al.
Published: (2020-01-01) -
Exploration of the mechanism of 5-Methylcytosine promoting the progression of hepatocellular carcinoma
by: Qiyao Zhang, et al.
Published: (2025-02-01) -
Regulation of T Helper 17 by Bacteria: An Approach for the Treatment of Hepatocellular Carcinoma
by: Cecilia Ying Ju Sung, et al.
Published: (2012-01-01) -
Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis
by: Fengle Jiang, et al.
Published: (2025-01-01)